• Arrowhead Pharmaceuticals (NASDAQ:ARWR) Earns Overweight Rating from Piper Sandler

    Источник: Buzz FX / 08 окт 2024 11:21:10   America/Chicago


    Arrowhead Pharmaceuticals (NASDAQ:ARWR) Earns Overweight Rating from Piper Sandler Written by MarketBeat October 8, 2024 Share Link copied to clipboard. Arrowhead Pharmaceuticals ( NASDAQ:ARWR - Get Free Report ) 's stock had its "overweigh
    Read more...
Опубликовать